IMVT - Immunovant, Inc.
NEXT EARNINGS:
May 27, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$35.67
DETAILS
HIGH:
$50.00
LOW:
$16.00
MEDIAN:
$41.00
CONSENSUS:
$35.67
UPSIDE:
30.23%
Market Cap:
5.57B
Volume:
811,128
Avg Volume:
1,616,878
52 Week Range:
12.72-27.923
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.62
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
362
IPO Date:
2019-06-21
EPS (TTM):
-2.73
P/E Ratio:
-6.26
Revenue (TTM):
N/A
Total Assets:
776.22M
Total Debt:
98,000
Cash & Equiv:
713.97M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-61.9%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-06 | $-0.61 | $-0.72 | +15.3% | — | — | — |
| 2025-11-10 | $-0.73 | $-0.72 | -1.4% | — | — | — |
| 2025-08-11 | $-0.60 | $-0.69 | +13.0% | — | — | — |
| 2025-05-29 | $-0.64 | $-0.71 | +10.3% | — | — | — |
| 2025-02-06 | $-0.76 | $-0.73 | -4.1% | — | — | — |
| 2024-11-07 | $-0.74 | $-0.60 | -23.3% | — | — | — |
| 2024-08-06 | $-0.60 | $-0.53 | -13.2% | — | — | — |
| 2024-05-29 | $-0.52 | $-0.43 | -20.9% | — | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (413.84M) | (259.34M) | (210.96M) | (156.73M) | (107.43M) | (66.39M) | (448) | (136.74M) |
| EPS | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 | -1.54 | 0.00 | -13.68 |
| Total Assets | 776.22M | 666.71M | 405.84M | 515.56M | 412.49M | 109.39M | 405,000 | 113,170 |
| Total Debt | 98,000 | 138,000 | 1.22M | 2.36M | 3.42M | 3.19M | 300,000 | 0 |
| Cash & Equivalents | 713.97M | 635.37M | 376.53M | 493.82M | 400.15M | 100.57M | 325,000 | 0 |
| Operating Cash Flow | (375.87M) | (214.23M) | (188.19M) | (106.11M) | (83.33M) | (53.36M) | (28.55M) | (128.30M) |
| Free Cash Flow | (376.63M) | (214.59M) | (188.39M) | (106.37M) | (83.54M) | (53.39M) | (28.60M) | (128.30M) |
| FCF per Share | -2.48 | -1.55 | -1.53 | -0.97 | -0.95 | -1.24 | -1.99 | -12.83 |
| Book Value | 707.45M | 617.76M | 362.49M | 469.82M | 391.48M | 94.07M | 24,552 | (1.50M) |
| Cash & ST Investments | 713.97M | 635.37M | 376.53M | 493.82M | 400.15M | 100.57M | 325,000 | 0 |
| ROC Equity | -0.58 | -0.42 | -0.58 | -0.33 | -0.27 | -0.71 | -0.02 | N/A |